Pure Global appoints AI expert to cut MedTech costs

Pure Global has announced the appointment of Ran Chen as Chief Technology Officer to lead the company's development of AI-based regulatory automation for medical device manufacturers.

Ran Chen joins Pure Global after serving as Director of Machine Learning at Tubi TV, where he was responsible for building the streaming platform's machine learning infrastructure and leading the development of over 70 real-time models that powered content personalisation. In his new role, Chen is expected to focus on agentic AI tools designed to automate tasks such as translation, classification, and document generation, with the aim of cutting regulatory delays and costs for MedTech companies.

Regulatory delays in the medical device industry are a significant concern, often costing manufacturers over USD $55,000 per day. These delays not only impact patient access to new medical devices but also impose a substantial financial burden on manufacturers. Pure Global's AI-powered compliance platform aims to address these issues through automation and streamlining of regulatory submission processes.

"With Ran as CTO, we're accelerating our ability to build and scale the tools our clients need. The impact is already clear as our AI agents are showing strong results across translation, classification, and document building," Praising the new appointment, DJ Fang, Co-founder and Chief Operating Officer of Pure Global, said.

During his time at Tubi TV, Chen established the company's machine learning infrastructure from the ground up and played a role in the platform's growth within the competitive video streaming sector in the United States. As CTO at Pure Global, he is tasked with further strengthening the company's AI capabilities and underlying data systems. Chen's priorities will include speeding up the development of tools for classification, translation, document generation, and gap analysis, which are all critical to medical device registration. He is also expected to collaborate closely with clients to ensure platform solutions are tailored to their needs and scalable across multiple markets.

"I'm excited to join Pure Global and apply my machine learning experience to medical device regulation, a space where technology can make a real difference. My focus is on using agentic AI to reduce delays and simplify global market access. We build every tool with one goal in mind: helping our clients move faster with less friction," Ran Chen said,  commenting on his new role.

Over the past two years, Pure Global has expanded its international infrastructure by establishing legal entities and partnerships in more than 30 key markets worldwide. This network is intended to allow the company to combine AI automation with local regulatory expertise, helping to reduce unnecessary delays and facilitate faster market access for clients operating in different regions.

The company's approach is centred on automating some of the most time-consuming regulatory steps, with the intention of enabling medical device manufacturers to scale efficiently and respond to evolving market and regulatory requirements. Chen's cross-industry experience and previous track record in scaling AI solutions are seen by Pure Global's leadership as strengthening the company's strategy to address regulatory complexities in the MedTech sector.

DJ Fang highlighted that the integration of advanced AI into regulatory processes is already producing measurable improvements in operational efficiency for clients. Chen's appointment is regarded by the company as a significant milestone in advancing its mission to facilitate reliable and timely global market access for healthcare technologies.